Closing Thoughts on the Impact of PSMA-PET Imaging in Prostate Cancer

Amar Kishan, MD, highlights findings showing that MRI-guided SBRT is superior to CT-guided SBRT in localized prostate cancer.

The PSE test was shown to improve the predictive accuracy of a standard PSA test from 55% to 94%.

“Localized prostate cancer is a very complicated disease space,” says Aaron A. Laviana, MD, MBA.

The addition of SBRT to upfront abiraterone acetate and prednisone (AAP) reduced the risk of disease progression or death by 65% compared with AAP alone in patients with oligometastatic castration-resistant prostate cancer.

“[These] results imply that prostate cancer survival could be improved, especially in historically under-served groups, by improving the timeliness of access to medical care," says Sean Clouston, PhD.